DrugPatentWatch Database Preview
Changzhou Pharm Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CHANGZHOU PHARM, and what generic and branded alternatives to CHANGZHOU PHARM drugs are available?
CHANGZHOU PHARM has three approved drugs.
Summary for Changzhou Pharm
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Changzhou Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-001 | Oct 31, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Changzhou Pharm | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 209402-001 | Oct 7, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-004 | Oct 31, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-002 | Oct 31, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
